Country for PR: United States
Contributor: PR Newswire New York
Thursday, April 25 2019 - 05:41
AsiaNet
Beta-Alanine for Food Application Receives Approval from Japanese Ministry of Health, Labor and Welfare
CARLSBAD, Calif., Apr. 25, 2019 /PRNewswire-AsiaNet/ --

-- NAI to Immediately Enter Japanese Market with CarnoSyn(R) Beta-Alanine

The public announcement of the approval of beta-alanine in the Japanese food 
market was made on March 25th via the official page of the Ministry of Health, 
Labor and Welfare of Japan. Natural Alternatives International, Inc. ("NAI") 
(Nasdaq: NAII), a leading formulator, and marketer of customized nutritional 
supplements, spent nearly three years navigating the application process and 
was instrumental in this premier achievement. 

"NAI applied to the Ministry of Health, Labor and Welfare for use of 
beta-alanine in food products in the Japanese marketplace. We received 
application confirmation in May 2016 and have worked diligently since that time 
to gain approval. We are proud to have provided assistance in opening the 
market and in ultimately gaining beta-alanine approval as a food ingredient in 
Japan for the first time," stated Ken Wolf, NAI's President. "NAI looks forward 
to entering the market with its CarnoSyn(R) beta-alanine, the only beta-alanine 
to receive New Dietary Ingredient Status from the FDA in the United States."

With the March 25th passing of proposal number 495180287, NAI fully intends to 
support Japanese market needs by participating in key 2019 industry tradeshows 
and conferences. Dr. Di Tan, Director of Scientific Affairs for CarnoSyn(R), 
recently attended the Health Food Expo, April 9-10, and will attend two 
additional conferences in Tokyo over the coming months: the IFIA and HEF 
International Food Ingredients & Additives Exhibition and Conference, May 
22-24, and the Sportec and Health Fitness Japan exhibition, July 9-11.

"CarnoSyn(R) beta-alanine is widely recognized as a patented, high-quality 
ingredient of choice among companies wishing to use only the safest ingredients 
in their products. Our CarnoSyn(R) beta-alanine is available for sale 
immediately in Japan to support our efforts in the Japanese market," noted 
Nicole Burbank, Vice President of CarnoSyn(R) Brands.

NAI is partnering with Shimizu Chemical Corporation to provide exclusive 
distribution of CarnoSyn(R) beta-alanine in Japan. Shimizu is a leading company 
in nutritional sciences in Japan, offering a wide range of products and 
services in various industries from pharmaceuticals and foods to cosmetics and 
sports nutrition. With its unique solutions and long-standing expertise, 
Shimizu continues to innovate globally. Its services include managing and 
leading contract manufacturing services to fulfill a variety of customer needs 
to produce finished products containing CarnoSyn(R) beta-alanine in a variety 
of forms, from nutritional supplements to all types of food products.

"We are committed to supporting NAI and promoting CarnoSyn(R) beta-alanine in 
the newly opened Japanese marketplace", said Ryusuke Shimizu, President and COO 
of Shimizu Chemical Corporation. "In addition to our 20+ year relationship with 
NAI, we are confident we can leverage our knowledge and expertise within Japan 
and beyond to create a successful market expansion and cultivate new customer 
partnerships."

About CarnoSyn(R) Brands:
CarnoSyn(R) Brands feature two clinically studied, patented ingredients 
available exclusively from Natural Alternatives International, Inc.: 
CarnoSyn(R) instant release beta-alanine and SR CarnoSyn(R) sustained release 
beta-alanine. In 2019, CarnoSyn(R) beta-alanine successfully obtained NDI 
status from the FDA. In the sports nutrition segment, both ingredients are well 
known to deliver benefits for athletic performance: Increased strength, 
enhanced endurance, faster recovery and greater mental focus. 

SR CarnoSyn(R) is an advanced delivery form of CarnoSyn(R), which delivers 
higher dosing levels of beta-alanine, and is proven to provide benefits for 
both wellness and healthy aging. In 2017, SR CarnoSyn(R) was determined to be 
safe through independent scientific procedures, thus satisfying the technical 
element of the Generally Recognized as Safe (GRAS) determination. The GRAS 
affirmation allows NAI to broaden their product offerings beyond the sports 
nutrition space and focus on the dietary supplement and food and beverage 
industries, including medical and other fortified food products.   

About NAI:
NAI, headquartered in Carlsbad, California, is a leading formulator, 
manufacturer and marketer of nutritional supplements and provides strategic 
partnering services to its customers. NAI's comprehensive partnership approach 
offers a wide range of innovative nutritional products and services to our 
clients including: scientific research, clinical studies, proprietary 
ingredients, customer-specific nutritional product formulation, product testing 
and evaluation, marketing management and support, packaging and delivery system 
design, regulatory review and international product registration assistance. 
For more information about NAI, please visit www.nai-online.com.  

This press release contains forward-looking statements within the meaning of 
Section 21E of the Securities Exchange Act of 1934 that are not historical 
facts and information. These statements represent our intentions, expectations 
and beliefs concerning future events, including, among other things, our future 
revenue profits and financial condition, our ability to maintain our patents, 
generate revenues from the commercialization of our patents and trademarks, 
secure compliance with our intellectual property rights, and develop, maintain 
or increase sales to new and existing customers, as well as future economic 
conditions and the impact of such conditions on our business. We wish to 
caution readers that these statements involve risks and uncertainties that 
could cause actual results and outcomes for future periods to differ materially 
from any forward-looking statement or views expressed herein. NAI's financial 
performance and the forward-looking statements contained herein are further 
qualified by other risks, including those set forth from time to time in the 
documents filed by us with the Securities and Exchange Commission, including 
our most recent Annual Report on Form 10-K.

CONTACT:
Renee Michaelson, CarnoSyn(R) Marketing Manager, Natural Alternatives 
International, Inc., at +1-760-736-7700 or info@nai-online.com.
Websites: http://www.nai-online.com and http://www.carnosyn.com/ and 
http://www.srcarnosyn.com/ 

Ryusuke Shimizu, President & COO, Shimizu Chemical Corporation, at 
+81-848-68-0371 or carnosyn@shimizuchemical.co.jp
Website: http://www.shimizuchemical.co.jp 

SOURCE: Natural Alternatives International, Inc.
Translations

Japanese